Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

NCT03435627 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03435627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
February 26, 2018
Completion date
January 18, 2022
Enrollment
71 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorder, noonan syndrome